Clinical Applications
Center for Chronic Disorders of Aging

Clinical Trials and PCOM Affiliates

The CCDA has fostered significant collaboration between both independent clinical departments and between clinical and basic science departments at PCOM.

Studies related to the underlying mechanisms of action of various clinical therapies in individuals with Parkinson's Disease (as well as the effect of the osteopathic lymphatic pump generally) has led to a close working relationship between the academic departments of Osteopathic Manipulative Medicine (OMM), Bio-Medical Sciences and Geriatrics. Equipment to measure nitric oxide (as a metabolite of eNOS) was obtained to support work in our departments as a consequence of the CCDA collaboration.

Clinical Trials with Other Institutions

The CCDA has fostered significant collaboration between various PCOM researchers and researchers at other institutions. 

Rowan University and New Jersey Institute for Successful Aging

The CCDA has been actively involved in establishing working relationships with Rowan University School of Osteopathic Medicine and New Jersey Institute for Successful Aging at Rowan University to develop clinical trial approaches for Alzheimer's disease.

Drexel University and Premier Research Group

In addition, ongoing collaborative efforts are being pursued with Drexel University and Premier Research Group to develop an antibiotic clinical trial for treating Alzheimer's disease.

Department of Defense and Veterans Affairs

CCDA researchers have also completed a five-state collaborative project for the Department of Defense that included five Veterans Affairs Medical Centers and two osteopathic colleges documenting the role of progressive maximum effort exercise in modifying strength, gait, cognition and quality of life in individuals with multiple sclerosis.

International

A CCDA researcher also trained members of a clinical research team in Finland to conduct a collaborative research project to investigate use of OMT and a pelvic orthotic device (LevitorA(R)) to decrease back pain and increase function in individuals with lumbar spondylolisthesis and hyperlordosis.